Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 – A rapid epidemiological and virological assessment

Eurosurveillance

Volumn 21, Issue 14, 2016, Pages

  Emborg, Hanne Dorthe ^a   Krause, T G ^a   Nielsen, L ^b   Thomsen, M K ^c   Christiansen, C B ^d   Skov, M N ^e   Nielsen, X C ^f   Weinreich, L S ^g   Fischer, T K ^a   Ronn J ^a   Trebbien, R ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f SLAGELSE HOSPITAL   (Denmark)

^g AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ADULT; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ARTICLE; DENMARK; DNA SEQUENCE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A (H1N1); INFLUENZA A VIRUS (H1N1); INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; AGED; CASE CONTROL STUDY; FEMALE; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; OUTCOME ASSESSMENT; PANDEMICS; SEASON; SENTINEL SURVEILLANCE; STATISTICS AND NUMERICAL DATA; VACCINATION; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PANDEMICS; SEASONS; SENTINEL SURVEILLANCE; VACCINATION; VACCINE POTENCY;

EID: 84963612106     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.14.30189     Document Type: Article

References (16)

1. European Centre for Disease Prevention and Control (ECDC). Seasonal influenza 2015-2016 in the EU/EEA countries. Risk assessment. Stockholm: ECDC; 2016. Available from: http: // ecdc. europa. eu/en/publications/Publications/seasonalinfluenza-risk-assessment-2015-2016. pdf
2. MiBa Board of Representatives, Voldstedlund M, Haarh M, Molbak K. The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill. 2014; 19(1): 20667. DOI: 10. 2807/1560-7917. ES2014. 19. 1. 20667 PMID: 24434175
3. Grove Krause T, Jakobsen S, Haarh M, Molbak K. The Danish vaccination register. Euro Surveill. 2012; 17(17): 20155. PMID: 22551494
4. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999; 46(3): 263-8. PMID: 10421985
5. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6. 0. Mol Biol Evol. 2013; 30(12): 2725-9. DOI: 10. 1093/molbev/mst197 PMID: 24132122
6. FluSurver. Influenza surveillance-prepared for next wave. Singapore; A*STAR Bioinformatics Institute. [Accessed: 14 Mar 2016]. Available from: http: //flusurver. bii. a-star. edu. sg/
7. World Health Organization (WHO) Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva: WHO; 2011. Available from: http: //apps. who. int/iris/ bitstream/10665/44518/1/9789241548090_eng. pdf
8. Trebbien R, Andersen B, Ronn J, McCauley J, Fischer TK. ESwab challenges influenza virus propagation in cell cultures. Euro Surveill. 2014; 19(50): 20995. DOI: 10. 2807/1560-7917. ES2014. 19. 50. 20995 PMID: 25597539
9. Kissling E, Valenciano M. Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study. Euro Surveill. 2016; 21(6): 30134. DOI: 10. 2807/1560-7917. ES. 2016. 21. 6. 30134 PMID: 26898240
10. Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results. Euro Surveill. 2016; 21(13): 30179.
11. Chiu SS, Feng S, Chan KH, Lo JY, Chan EL, So LY, et al. Hospitalbased vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14. Vaccine. 2016; pii: S0264-410X(16)30005-6
12. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014; 58(3): 319-27. DOI: 10. 1093/cid/cit736 PMID: 24235265
13. Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis. 2014; 210(1): 126-37. DOI: 10. 1093/infdis/ jiu048 PMID: 24446529
14. European Centre for Disease Prevention and Control (ECDC). Influenza situation in week 9 2016. Stockholm: ECDC; 2016. Available from: http: //ecdc. europa. eu/en/healthtopics/ seasonal_influenza/epidemiological_data/Pages/Latest_ surveillance_data. aspx
15. Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horvath JK, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Euro Surveill. 2016; 21(7): 30139. DOI: 10. 2807/1560-7917. ES. 2016. 21. 7. 30139 PMID: 26924024
16. Eurosurveillance editorial team., WHO recommendations on the composition of the 2016/17 influenza virus vaccines in the northern hemisphere. Euro Surveill. 2016; 21(8): 30147.